The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) includes simple steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. The gut-derived endotoxin plays an essential role in the pathophysiological development and progression of NAFLD. By using rat models of choline-deficient/L-amino acid-defined (CDAA)-diet-induced NAFLD, we examined whether MIYAIRI 588--a butyrate-producing probiotic--prevents the progression of pathophysiological changes from steatosis to hepatocarcinogenesis. In vivo experiments showed that treatment with MIYAIRI 588 reduced CDAA-diet-induced hepatic lipid deposition and significantly improved the triglyceride content, insulin resistance, serum endotoxin levels, and hepatic inflammatory indexes. We also found that MIYAIRI 588 substantially increased the activation of hepatic adenosine 5'-monophosphate-activated protein kinase (AMPK) and AKT and the expression of lipogenesis- or lipolysis-related proteins. MIYAIRI 588 also improved CDAA-diet-induced delocalization and substantially decreased the expression of the tight-junction proteins intestinal zonula occluden-1 and occludin in CDAA-diet-fed rats. Further, the MIYAIRI 588-treated rats also showed remarkable induction of nuclear factor erythoid 2-related factor 2 (Nrf2) and its targeted antioxidative enzymes, which suppressed hepatic oxidative stress. In vitro studies revealed that treatment with sodium butyrate (NaB) also activated AMPK and AKT and enhanced Nrf2 expression by precluding ubiquitination, thereby increasing the half-life of the Nrf2 protein. Pharmacological studies and siRNA knockdown experiments showed that NaB-mediated AMPK activation induced the phosphorylation and nuclear translocation of Sirtuin 1, leading to the increased assembly of mammalian TOR complex 2 and phosphorylation of AKT at Ser473 and subsequent induction of Nrf2 expression and activation. These favorable changes caused an obvious decrease in hepatic fibrous deposition, GST-P-positive foci development, and hepatocarcinogenesis. Our data clearly established that the probiotic MIYAIRI 588 has beneficial effects in the prevention of NAFLD progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819 · cited 16×
“Although NAFLD is benign, recent studies indicate that around 40% of NAFLD patients progress to fibrosis and .50% develop NASH after 4–13 years [2,3].”
BackgroundInfluentialAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300
Kim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
Human nutrition, the gut microbiome and the immune system
Kau, A. L., Ahern, P. P., Griffin, N. W., Goodman, A. L., & Gordon, J. I. (2011) · Nature · doi:10.1038/nature10213 · Cited by 2,588
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Butyrate improves insulin sensitivity and increases energy expenditure in mice
Gao, Z., Yin, J., Zhang, J., Ward, R. E., Martin, R. J., Lefevre, M., Cefalu, W. T., & Ye, J. (2009) · Diabetes · doi:10.2337/db08-1637 · Cited by 2,204 · cited 1×
“Dietary supplementation of butyrate induces the activation of adenosine 59-monophosphate-activated protein kinase (AMPK), thereby preventing and treating high-fat-diet-induced obesity and insulin resistance in mice [17].”
BackgroundPeng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Sirtuins as regulators of metabolism and healthspan
Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3293 · Cited by 2,008
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,778
Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., & Yamamoto, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16023 · Cited by 1,460
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434 · cited 1×
“with NAFLD of different histological severities and associated with small intestinal bacterial overgrowth and increased intestinal permeability [9].”
BackgroundPRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236 · cited 1×
“3% CHAPS, and proteinase inhibitor cocktail [Sigma]) were carried out as described previously [34,35,36].”
MethodAMP-activated protein kinase signaling in metabolic regulation
Long, Y. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29044 · Cited by 1,098
Adiponectin and AdipoR1 Regulate PGC-1α and Mitochondria by Ca2+ and AMPK/SIRT1
Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M., et al. (2010) · Nature · doi:10.1038/nature08991 · Cited by 971
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation
Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., Kotsuji, T., Otsuka, F., Roop, D. R., et al. (2003) · Nature Genetics · doi:10.1038/ng1248 · Cited by 883
Brun, P., Castagliuolo, I., Leo, V. D., Buda, A., Pinzani, M., Palù, G., & Martines, D. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00024.2006 · Cited by 864
Ouchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T., & Walsh, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310389200 · Cited by 759
Liu, G.-H., Qu, J., & Shen, X. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.002 · Cited by 697
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
MUSSO, G., GAMBINO, R., & CASSADER, M. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.08.001 · Cited by 681
Activation of mTORC2 by Association with the Ribosome
Zinzalla, V., Stracka, D., Oppliger, W., & Hall, M. N. (2011) · Cell · doi:10.1016/j.cell.2011.02.014 · Cited by 654
Kobayashi, M., Li, L., Iwamoto, N., Nakajima-Takagi, Y., Kaneko, H., Nakayama, Y., Eguchi, M., Wada, Y., Kumagai, Y., & Yamamoto, M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01080-08 · Cited by 638
Toll-Like Receptor 4 Is Involved in the Development of Fructose-Induced Hepatic Steatosis in Mice†
Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S., Bischoff, S. C., & Bergheim, I. (2009) · Hepatology · doi:10.1002/hep.23122 · Cited by 562
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin
Bergheim, I., Weber, S., Vos, M., Krämer, S., Volynets, V., Kaserouni, S., McClain, C. J., & Bischoff, S. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.035 · Cited by 522
Zang, M., Zuccollo, A., Hou, X., Nagata, D., Walsh, K., Herscovitz, H., Brecher, P., Ruderman, N. B., & Cohen, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408149200 · Cited by 453
Wang, R.-H., Kim, H.-S., Xiao, C., Xu, X., Gavrilova, O., & Deng, C.-X. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46243 · Cited by 314
Phosphorylation Regulates SIRT1 Function
Sasaki, T., Maier, B., Koclega, K. D., Chruszcz, M., Gluba, W., Stukenberg, P. T., Minor, W., & Scrable, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004020 · Cited by 290
JNK1 Phosphorylates SIRT1 and Promotes Its Enzymatic Activity
Nasrin, N., Kaushik, V. K., Fortier, E., Wall, D., Pearson, K. J., de Cabo, R., & Bordone, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008414 · Cited by 271
Prevalence, gender, ethnic variations, and prognosis of NASH
Hashimoto, E., & Tokushige, K. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-010-0311-8 · Cited by 264
Velayudham, A., Dolganiuc, A., Ellis, M., Petrasek, J., Kodys, K., Mandrekar, P., & Szabo, G. (2009) · Hepatology · doi:10.1002/hep.22711 · Cited by 263
Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis
Chowdhry, S., Nazmy, M. H., Meakin, P. J., Dinkova-Kostova, A. T., Walsh, S. V., Tsujita, T., Dillon, J. F., Ashford, M. L. J., & Hayes, J. D. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.007 · Cited by 261
Rationale for the luminal provision of butyrate in intestinal diseases
Wächtershäuser, A., & Stein, J. (2000) · European Journal of Nutrition · doi:10.1007/s003940070020 · Cited by 258
Prevention of antibiotic‐associated diarrhea in children by Clostridium butyricum MIYAIRI
SEKI, H., SHIOHARA, M., MATSUMURA, T., MIYAGAWA, N., TANAKA, M., KOMIYAMA, A., & KURATA, S. (2003) · Pediatrics International · doi:10.1046/j.1442-200x.2003.01671.x · Cited by 253
Self-citationGarcía-Trevijano, E. R., Iraburu, M. J., Fontana, L., Domínguez-Rosales, J. A., Auster, A., Covarrubias-Pinedo, A., & Rojkind, M. (1999) · Hepatology · doi:10.1002/hep.510290346 · Cited by 236
Li, X.-N., Song, J., Zhang, L., LeMaire, S. A., Hou, X., Zhang, C., Coselli, J. S., Chen, L., Wang, X. L., Zhang, Y., et al. (2009) · Diabetes · doi:10.2337/db08-1512 · Cited by 236
Vernia, P., Annese, V., Bresci, G., D’Albasio, G., D’Incà, R., Giaccari, S., Ingrosso, M., Mansi, C., Riegler, G., Valpiani, D., et al. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01130.x · Cited by 217
Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction
Schenk, S., McCurdy, C. E., Philp, A., Chen, M. Z., Holliday, M. J., Bandyopadhyay, G. K., Osborn, O., Baar, K., & Olefsky, J. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58554 · Cited by 197 · cited 2×
“Liverspecific deletion of the Sirt1 gene in mice is reported to cause liver steatosis, insulin resistance, and oxidative stress in various organs [40].”
BackgroundKodama, Y., Kisseleva, T., Iwaisako, K., Miura, K., Taura, K., De Minicis, S., Österreicher, C. H., Schnabl, B., Seki, E., & Brenner, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.045 · Cited by 195
Horike, N., Sakoda, H., Kushiyama, A., Ono, H., Fujishiro, M., Kamata, H., Nishiyama, K., Uchijima, Y., Kurihara, Y., Kurihara, H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802537200 · Cited by 192
Musso, G., Gambino, R., & Cassader, M. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283347ebb · Cited by 182
Gut-Liver Axis and Sensing Microbes
Szabo, G., Bala, S., Petrasek, J., & Gattu, A. (2010) · Digestive Diseases · doi:10.1159/000324281 · Cited by 179
Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival
Liu, X.-M., Peyton, K. J., Shebib, A. R., Wang, H., Korthuis, R. J., & Durante, W. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00749.2010 · Cited by 171
Sugimoto, H., Okada, K., Shoda, J., Warabi, E., Ishige, K., Ueda, T., Taguchi, K., Yanagawa, T., Nakahara, A., Hyodo, I., et al. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00296.2009 · Cited by 160
Amato, S., Liu, X., Zheng, B., Cantley, L. C., RAKIC, P. T., & Man, H. (2011) · Science · doi:10.1126/science.1201678 · Cited by 148
Kumar, A., Wu, H., Collier-Hyams, L. S., Kwon, Y.-M., Hanson, J. M., & Neish, A. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.538 · Cited by 145
IKEDA, H., NISHI, S., & SAKAI, M. (2004) · Biochemical Journal · doi:10.1042/bj20031948 · Cited by 136
Watanabe, T., Niioka, M., Hozawa, S., Kameyama, K., Hayashi, T., Arai, M., Ishikawa, A., Maruyama, K., & Okazaki, I. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80363-3 · Cited by 109
Self-citationIron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats
Minamiyama, Y., Takemura, S., Kodai, S., Shinkawa, H., Tsukioka, T., Ichikawa, H., Naito, Y., Yoshikawa, T., & Okada, S. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00620.2009 · Cited by 102
Sakamoto, K., Iwasaki, K., Sugiyama, H., & Tsuji, Y. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0762 · Cited by 94
Miyoshi, M., Sakaki, H., Usami, M., Iizuka, N., Shuno, K., Aoyama, M., & Usami, Y. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.09.012 · Cited by 93
Okamoto, T., Sasaki, M., Tsujikawa, T., Fujiyama, Y., Bamba, T., & Kusunoki, M. (2000) · Journal of Gastroenterology · doi:10.1007/s005350050358 · Cited by 91 · cited 1×
“butyricum is used as a probiotic for treating and preventing non-antimicrobialinduced diarrhea, antimicrobial-associated diarrhea, and constipation in humans [12,13].”
BackgroundMorino, S., Kondo, T., Sasaki, K., Adachi, H., Suico, M. A., Sekimoto, E., Matsuda, T., Shuto, T., Araki, E., & Kai, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004068 · Cited by 87
Okada, K., Warabi, E., Sugimoto, H., Horie, M., Tokushige, K., Ueda, T., Harada, N., Taguchi, K., Hashimoto, E., Itoh, K., et al. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0552-9 · Cited by 80
Weerachayaphorn, J., Cai, S., Soroka, C. J., & Boyer, J. L. (2009) · Hepatology · doi:10.1002/hep.23151 · Cited by 77
Laviña, B., Gracia‐Sancho, J., Rodrı́guez-Vilarrupla, A., Chu, Y., Heistad, D. D., Bosch, J., & García‐Pagán, J. C. (2008) · Gut · doi:10.1136/gut.2008.149880 · Cited by 73
Matrix Metalloproteinase-13 Promotes Recovery from Experimental Liver Cirrhosis in Rats
Endo, H., Niioka, M., Sugioka, Y., Itoh, J., Kameyama, K., Okazaki, I., Ala‐aho, R., Kähäri, V., & Watanabe, T. (2011) · Pathobiology · doi:10.1159/000328841 · Cited by 69
Self-citationRegulation of glutathione transferase P: A tumor marker of hepatocarcinogenesis
Sakai, M., & Muramatsu, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.174 · Cited by 63
Watanabe, T., Niioka, M., Ishikawa, A., Hozawa, S., Arai, M., Maruyama, K., Okada, A., & Okazaki, I. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00177-5 · Cited by 60
Self-citationEndo, H., Sugioka, Y., Nakagi, Y., Saijo, Y., & Yoshida, T. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10696 · Cited by 35
Self-citationKoketsu, Y., Sakoda, H., Fujishiro, M., Kushiyama, A., Fukushima, Y., Ono, H., Anai, M., Kikuchi, T., Fukuda, T., Kamata, H., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00253.2007 · Cited by 33
Cited by
Short-chain fatty acids in control of body weight and insulin sensitivity
Canfora, E. E., Jocken, J. W., & Blaak, E. E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.128 · Cited by 2,298
Antioxidant Properties of Probiotic Bacteria
Wang, Y., Wu, Y., Wang, Y., Xu, H., Mei, X., Yu, D., Wang, Y., & Li, W. (2017) · Nutrients · doi:10.3390/nu9050521 · Cited by 917
Singh, V., Lee, G., Son, H., Koh, H., Kim, E. S., Unno, T., & Shin, J.-H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1103836 · Cited by 705
Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit
Li, Z., Yi, C.-X., Katiraei, S., Kooijman, S., Zhou, E., Chung, C. K., Gao, Y., van den Heuvel, J. K., Meijer, O. C., Berbée, J. F. P., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314050 · Cited by 674
Feng, T., & Wang, J. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1801944 · Cited by 621
Metadata
- Authors
- Endo, H., Niioka, M., Kobayashi, N., Tanaka, M., & Watanabe, T.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-16
- Volume
- 8
- Issue
- 5
- Pages
- e63388
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2083725282
- Cited by
- 336
- References
- 64
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.